This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, J. M. Search for Related Content PubMed PubMed Citation Articles by Brown, J. M.

The Hypoxic Cell

A Target for Selective Cancer Therapy—Eighteenth Bruce F. Cain Memorial Award Lecture¹

Cancer Biology Research Laboratory, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305

ABSTRACT

It has been appreciated for more than 50 years that very low levels of oxygenation, or hypoxia, both protect cells from killing by X-irradiation and are present in solid tumors but not in normal tissues. Until recently, however, there has been no definitive proof that hypoxia in human tumors contributes to radiotherapy treatment failure. We now know that hypoxia in solid tumors is not only a major problem for radiation therapy but also leads to resistance to most anticancer drugs and, importantly, appears to accelerate malignant progression and increase metastasis. To date, efforts to overcome the problem of hypoxia have had only limited success. However, the recent development of new drugs that are nontoxic until they are activated in the hypoxic cell opens a new era. The first of these new drugs to be tested clinically, tirapazamine, a drug that is highly toxic to hypoxic but not aerobic cells, has already demonstrated efficacy in selective potentiation of cisplatin in randomized Phase III trials with non-small cell lung cancer. The unique presence of hypoxic cells in human tumors provides an important target for selective cancer therapy.

This article has been cited by other articles:

				H. Muniyappa, S. Song, C. K. Mathews, and K. C. Das Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia: INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL J. Biol. Chem., June 19, 2009; 284(25): 17069 - 17081. [Abstract] [Full Text] [PDF]

				Y. Gu, A. V. Patterson, G. J. Atwell, S. B. Chernikova, J. M. Brown, L. H. Thompson, and W. R. Wilson Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A Mol. Cancer Ther., June 1, 2009; 8(6): 1714 - 1723. [Abstract] [Full Text] [PDF]

				M. Mehibel, S. Singh, E. C. Chinje, R. L. Cowen, and I. J. Stratford Effects of cytokine-induced macrophages on the response of tumor cells to banoxantrone (AQ4N) Mol. Cancer Ther., May 1, 2009; 8(5): 1261 - 1269. [Abstract] [Full Text] [PDF]

				M. P.S. Dunphy and J. S. Lewis Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET J. Nucl. Med., May 1, 2009; 50(Suppl_1): 106S - 121S. [Abstract] [Full Text] [PDF]

				T. F. Liu, J. Cai, D. M. Gibo, and W. Debinski Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin Clin. Cancer Res., January 1, 2009; 15(1): 160 - 168. [Abstract] [Full Text] [PDF]

				S. Cannito, E. Novo, A. Compagnone, L. Valfre di Bonzo, C. Busletta, E. Zamara, C. Paternostro, D. Povero, A. Bandino, F. Bozzo, et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells Carcinogenesis, December 1, 2008; 29(12): 2267 - 2278. [Abstract] [Full Text] [PDF]

				K. Helczynska, A.-M. Larsson, L. Holmquist Mengelbier, E. Bridges, E. Fredlund, S. Borgquist, G. Landberg, S. Pahlman, and K. Jirstrom Hypoxia-Inducible Factor-2{alpha} Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer Cancer Res., November 15, 2008; 68(22): 9212 - 9220. [Abstract] [Full Text] [PDF]

				J. H.E. Baker, J. Lam, A. H. Kyle, J. Sy, T. Oliver, S. J. Co, W. H. Dragowska, E. Ramsay, M. Anantha, T. J. Ruth, et al. Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin Clin. Cancer Res., November 15, 2008; 14(22): 7260 - 7271. [Abstract] [Full Text] [PDF]

				D. Bae, S. Lu, C. A. Taglienti, and A. M. Mercurio Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2 J. Biol. Chem., October 17, 2008; 283(42): 28074 - 28080. [Abstract] [Full Text] [PDF]

				J. S. Lewis, R. Laforest, F. Dehdashti, P. W. Grigsby, M. J. Welch, and B. A. Siegel An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix J. Nucl. Med., July 1, 2008; 49(7): 1177 - 1182. [Abstract] [Full Text] [PDF]

				S. Supiot, R. P. Hill, and R. G. Bristow Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53 Mol. Cancer Ther., April 1, 2008; 7(4): 993 - 999. [Abstract] [Full Text] [PDF]

				F. Dehdashti, P. W. Grigsby, J. S. Lewis, R. Laforest, B. A. Siegel, and M. J. Welch Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone) J. Nucl. Med., February 1, 2008; 49(2): 201 - 205. [Abstract] [Full Text] [PDF]

				J. G. Rajendran and D. A. Mankoff Beyond Detection: Novel Applications for PET Imaging to Guide Cancer Therapy J. Nucl. Med., June 1, 2007; 48(6): 855 - 856. [Full Text] [PDF]

				A. Wouters, B. Pauwels, F. Lardon, and J. B. Vermorken Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions Oncologist, June 1, 2007; 12(6): 690 - 712. [Abstract] [Full Text] [PDF]

				H. Yasuda, K. Nakayama, M. Watanabe, S. Suzuki, H. Fuji, S. Okinaga, A. Kanda, K. Zayasu, T. Sasaki, M. Asada, et al. Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma. Clin. Cancer Res., November 15, 2006; 12(22): 6748 - 6757. [Abstract] [Full Text] [PDF]

				L. M. Cher, C. Murone, N. Lawrentschuk, S. Ramdave, A. Papenfuss, A. Hannah, G. J. O'Keefe, J. I. Sachinidis, S. U. Berlangieri, G. Fabinyi, et al. Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas Using 18F-Fluoromisonidazole, 18F-FDG PET, and Immunohistochemical Studies J. Nucl. Med., March 1, 2006; 47(3): 410 - 418. [Abstract] [Full Text] [PDF]

				H. Yasuda, M. Yamaya, K. Nakayama, T. Sasaki, S. Ebihara, A. Kanda, M. Asada, D. Inoue, T. Suzuki, T. Okazaki, et al. Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non-Small-Cell Lung Cancer J. Clin. Oncol., February 1, 2006; 24(4): 688 - 694. [Abstract] [Full Text] [PDF]

				G. J. Kelloff, K. A. Krohn, S. M. Larson, R. Weissleder, D. A. Mankoff, J. M. Hoffman, J. M. Link, K. Z. Guyton, W. C. Eckelman, H. I. Scher, et al. The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development Clin. Cancer Res., November 15, 2005; 11(22): 7967 - 7985. [Abstract] [Full Text] [PDF]

				K. Hellauer, G. Lesage, A.-M. Sdicu, and B. Turcotte Large-Scale Analysis of Genes that Alter Sensitivity to the Anticancer Drug Tirapazamine in Saccharomyces cerevisiae Mol. Pharmacol., November 1, 2005; 68(5): 1365 - 1375. [Abstract] [Full Text] [PDF]

				Q. Zhu, E. B. Cronin, A. A. Currier, H. S. Vine, M. Huang, N. Chen, and C. Xu Benign versus Malignant Breast Masses: Optical Differentiation with US-guided Optical Imaging Reconstruction Radiology, October 1, 2005; 237(1): 57 - 66. [Abstract] [Full Text] [PDF]

				B. Solomon, D. Binns, P. Roselt, L. I. Weibe, G. A. McArthur, C. Cullinane, and R. J. Hicks Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging Mol. Cancer Ther., September 1, 2005; 4(9): 1417 - 1422. [Abstract] [Full Text] [PDF]

				X. Zhang, J. Li, D. P. Sejas, and Q. Pang Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells Blood, July 1, 2005; 106(1): 75 - 85. [Abstract] [Full Text] [PDF]

				M. P. L. Bard, A. Amelink, V. N. Hegt, W. J. Graveland, H. J. C. M. Sterenborg, H. C. Hoogsteden, and J. G. J. V. Aerts Measurement of Hypoxia-related Parameters in Bronchial Mucosa by Use of Optical Spectroscopy Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1178 - 1184. [Abstract] [Full Text] [PDF]

				A. Azqueta, G. Pachon, M. Cascante, E. E. Creppy, and A. Lopez de Cerain DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay Mutagenesis, May 1, 2005; 20(3): 165 - 171. [Abstract] [Full Text] [PDF]

				S.-O. Yoon, S. Shin, and A. M. Mercurio Hypoxia Stimulates Carcinoma Invasion by Stabilizing Microtubules and Promoting the Rab11 Trafficking of the {alpha}6{beta}4 Integrin Cancer Res., April 1, 2005; 65(7): 2761 - 2769. [Abstract] [Full Text] [PDF]

				J.-P. Piret, E. Minet, J.-P. Cosse, N. Ninane, C. Debacq, M. Raes, and C. Michiels Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid Cell Factor-1 Protects Hypoxic Cells against tert-Butyl Hydroperoxide-induced Apoptosis J. Biol. Chem., March 11, 2005; 280(10): 9336 - 9344. [Abstract] [Full Text] [PDF]

				G. Gasparini, R. Longo, M. Fanelli, and B. A. Teicher Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions J. Clin. Oncol., February 20, 2005; 23(6): 1295 - 1311. [Abstract] [Full Text] [PDF]

				W. H. Dragowska, C. Warburton, D. T.T. Yapp, A. I. Minchinton, Y. Hu, D. N. Waterhouse, K. Gelmon, K. Skov, J. Woo, D. Masin, et al. HER-2/neu Overexpression Increases the Viable Hypoxic Cell Population within Solid Tumors without Causing Changes in Tumor Vascularization Mol. Cancer Res., November 1, 2004; 2(11): 606 - 619. [Abstract] [Full Text] [PDF]

				J. Li, X. Zhang, D. P. Sejas, G. C. Bagby, and Q. Pang Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53 J. Biol. Chem., October 1, 2004; 279(40): 41275 - 41279. [Abstract] [Full Text] [PDF]

				T. Mikuni, G. He, S. Petryakov, M. M. Fallouh, Y. Deng, R. Ishihara, P. Kuppusamy, M. Tatsuta, and J. L. Zweier In vivo Detection of Gastric Cancer in Rats by Electron Paramagnetic Resonance Imaging Cancer Res., September 15, 2004; 64(18): 6495 - 6502. [Abstract] [Full Text] [PDF]

				S. Batra, C. P. Reynolds, and B. J. Maurer Fenretinide Cytotoxicity for Ewing's Sarcoma and Primitive Neuroectodermal Tumor Cell Lines Is Decreased by Hypoxia and Synergistically Enhanced by Ceramide Modulators Cancer Res., August 1, 2004; 64(15): 5415 - 5424. [Abstract] [Full Text] [PDF]

				J. G. Rajendran, D. A. Mankoff, F. O'Sullivan, L. M. Peterson, D. L. Schwartz, E. U. Conrad, A. M. Spence, M. Muzi, D. G. Farwell, and K. A. Krohn Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Clin. Cancer Res., April 1, 2004; 10(7): 2245 - 2252. [Abstract] [Full Text] [PDF]

				Z. Dong and J. Wang Hypoxia Selection of Death-resistant Cells: A ROLE FOR Bcl-XL J. Biol. Chem., March 5, 2004; 279(10): 9215 - 9221. [Abstract] [Full Text] [PDF]

				B. G. Siim, F. B. Pruijn, J. R. Sturman, A. Hogg, M. P. Hay, J. M. Brown, and W. R. Wilson Selective Potentiation of the Hypoxic Cytotoxicity of Tirapazamine by Its 1-N-Oxide Metabolite SR 4317 Cancer Res., January 15, 2004; 64(2): 736 - 742. [Abstract] [Full Text] [PDF]

				P. N. Lara Jr., P. Frankel, P. C. Mack, P. H. Gumerlock, I. Galvin, C. L. Martel, J. Longmate, J. H. Doroshow, H. J. Lenz, D. H. M. Lau, et al. Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: A California Cancer Consortium Phase I and Molecular Correlative Study Clin. Cancer Res., October 1, 2003; 9(12): 4356 - 4362. [Abstract] [Full Text] [PDF]

				R. L. Aft, J. S. Lewis, F. Zhang, J. Kim, and M. J. Welch Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose Cancer Res., September 1, 2003; 63(17): 5496 - 5504. [Abstract] [Full Text] [PDF]

				Z. Dong, J. Z. Wang, F. Yu, and M. A. Venkatachalam Apoptosis-Resistance of Hypoxic Cells: Multiple Factors Involved and a Role for IAP-2 Am. J. Pathol., August 1, 2003; 163(2): 663 - 671. [Abstract] [Full Text] [PDF]

				E.-J. Yeo, Y.-S. Chun, Y.-S. Cho, J. Kim, J.-C. Lee, M.-S. Kim, and J.-W. Park YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1 J Natl Cancer Inst, April 2, 2003; 95(7): 516 - 525. [Abstract] [Full Text] [PDF]

				F. HEDBORG, E. ULLERAS, L. GRIMELIUS, E. WASSBERG, P. H MAXWELL, B. HERO, F. BERTHOLD, F. SCHILLING, D. HARMS, B. SANDSTEDT, et al. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma FASEB J, April 1, 2003; 17(6): 598 - 609. [Abstract] [Full Text] [PDF]

				L. B. Harrison, M. Chadha, R. J. Hill, K. Hu, and D. Shasha Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes Oncologist, December 1, 2002; 7(6): 492 - 508. [Abstract] [Full Text] [PDF]

				K. B. Peters and J. M. Brown Tirapazamine: A Hypoxia-activated Topoisomerase II Poison Cancer Res., September 15, 2002; 62(18): 5248 - 5253. [Abstract] [Full Text] [PDF]

				L.-M. Postovit, M. A. Adams, G. E. Lash, J. P. Heaton, and C. H. Graham Oxygen-mediated Regulation of Tumor Cell Invasiveness. INVOLVEMENT OF A NITRIC OXIDE SIGNALING PATHWAY J. Biol. Chem., September 13, 2002; 277(38): 35730 - 35737. [Abstract] [Full Text] [PDF]

				B. F. Jordan, V. Gregoire, R. J. Demeure, P. Sonveaux, O. Feron, J. O'Hara, V. P. Vanhulle, N. Delzenne, and B. Gallez Insulin Increases the Sensitivity of Tumors to Irradiation: Involvement of an Increase in Tumor Oxygenation Mediated by a Nitric Oxide-dependent Decrease of the Tumor Cells Oxygen Consumption Cancer Res., June 1, 2002; 62(12): 3555 - 3561. [Abstract] [Full Text] [PDF]

				G. Hopfl, R. H. Wenger, U. Ziegler, T. Stallmach, O. Gardelle, R. Achermann, M. Wergin, B. Kaser-Hotz, H. M. Saunders, K. J. Williams, et al. Rescue of Hypoxia-inducible Factor-1{alpha}-deficient Tumor Growth by Wild-Type Cells Is Independent of Vascular Endothelial Growth Factor Cancer Res., May 1, 2002; 62(10): 2962 - 2970. [Abstract] [Full Text] [PDF]

				J. Golab, D. Olszewska, P. Mroz, K. Kozar, R. Kaminski, A. Jalili, and M. Jakobisiak Erythropoietin Restores the Antitumor Effectiveness of Photodynamic Therapy in Mice with Chemotherapy- induced Anemia Clin. Cancer Res., May 1, 2002; 8(5): 1265 - 1270. [Abstract] [Full Text] [PDF]

				A. Fyles, M. Milosevic, D. Hedley, M. Pintilie, W. Levin, L. Manchul, and R. P. Hill Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer J. Clin. Oncol., February 1, 2002; 20(3): 680 - 687. [Abstract] [Full Text] [PDF]

				A. Giatromanolaki, M. I. Koukourakis, E. Sivridis, J. Pastorek, C. C. Wykoff, K. C. Gatter, and A. L. Harris Expression of Hypoxia-inducible Carbonic Anhydrase-9 Relates to Angiogenic Pathways and Independently to Poor Outcome in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(21): 7992 - 7998. [Abstract] [Full Text] [PDF]

				M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. Simopoulos, J. Pastorek, C. C. Wykoff, K. C. Gatter, and A. L. Harris Hypoxia-regulated Carbonic Anhydrase-9 (CA9) Relates to Poor Vascularization and Resistance of Squamous Cell Head and Neck Cancer to Chemoradiotherapy Clin. Cancer Res., November 1, 2001; 7(11): 3399 - 3403. [Abstract] [Full Text] [PDF]

				A. Lal, H. Peters, B. St. Croix, Z. A. Haroon, M. W. Dewhirst, R. L. Strausberg, J. H. A. M. Kaanders, A. J. van der Kogel, and G. J. Riggins Transcriptional Response to Hypoxia in Human Tumors J Natl Cancer Inst, September 5, 2001; 93(17): 1337 - 1343. [Abstract] [Full Text] [PDF]

				N. Akakura, M. Kobayashi, I. Horiuchi, A. Suzuki, J. Wang, J. Chen, H. Niizeki, K.-i. Kawamura, M. Hosokawa, and M. Asaka Constitutive Expression of Hypoxia-inducible Factor-1{alpha} Renders Pancreatic Cancer Cells Resistant to Apoptosis Induced by Hypoxia and Nutrient Deprivation Cancer Res., September 1, 2001; 61(17): 6548 - 6554. [Abstract] [Full Text] [PDF]

				R. E. Bachelder, A. Crago, J. Chung, M. A. Wendt, L. M. Shaw, G. Robinson, and A. M. Mercurio Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells Cancer Res., August 1, 2001; 61(15): 5736 - 5740. [Abstract] [Full Text] [PDF]

				K. B. Peters, H. Wang, J. M. Brown, and G. Iliakis Inhibition of DNA Replication by Tirapazamine Cancer Res., July 1, 2001; 61(14): 5425 - 5431. [Abstract] [Full Text] [PDF]

				J. S. Lewis, T. L. Sharp, R. Laforest, Y. Fujibayashi, and M. J. Welch Tumor Uptake of Copper-Diacetyl-Bis(N4-Methylthiosemicarbazone): Effect of Changes in Tissue Oxygenation J. Nucl. Med., April 1, 2001; 42(4): 655 - 661. [Abstract] [Full Text]

				M. I. Koukourakis, A. Giatromanolaki, J. Skarlatos, L. Corti, S. Blandamura, M. Piazza, K. C. Gatter, and A. L. Harris Hypoxia Inducible Factor (HIF-1a and HIF-2a) Expression in Early Esophageal Cancer and Response to Photodynamic Therapy and Radiotherapy Cancer Res., March 1, 2001; 61(5): 1830 - 1832. [Abstract] [Full Text]

				J. S. Lewis, R. Laforest, T. L. Buettner, S.-K. Song, Y. Fujibayashi, J. M. Connett, and M. J. Welch Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy PNAS, January 30, 2001; 98(3): 1206 - 1211. [Abstract] [Full Text] [PDF]

				R. M. Salloum, N. T. Jaskowiak, H. J. Mauceri, S. Seetharam, M. A. Beckett, A. M. Koons, D. M. Hari, V. K. Gupta, C. Reimer, R. Kalluri, et al. NM-3, an Isocoumarin, Increases the Antitumor Effects of Radiotherapy without Toxicity Cancer Res., December 1, 2000; 60(24): 6958 - 6963. [Abstract] [Full Text]

				C. V. Ngo, M. Gee, N. Akhtar, D. Yu, O. Volpert, R. Auerbach, and A. Thomas-Tikhonenko An in Vivo Function for the Transforming Myc Protein: Elicitation of the Angiogenic Phenotype Cell Growth Differ., April 1, 2000; 11(4): 201 - 210. [Abstract] [Full Text]

				Z. Dong, M. A. Venkatachalam, J. Wang, Y. Patel, P. Saikumar, G. L. Semenza, T. Force, and J. Nishiyama Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia. HIF-1-INDEPENDENT MECHANISMS J. Biol. Chem., May 25, 2001; 276(22): 18702 - 18709. [Abstract] [Full Text] [PDF]

				P. A. Padilla and M. B. Roth Oxygen deprivation causes suspended animation in the zebrafish embryo PNAS, June 19, 2001; 98(13): 7331 - 7335. [Abstract] [Full Text] [PDF]